3M (MMM) Stock Forecast & Price Target

3M is viewed positively because its core Safety & Industrial and Transportation & Electronics businesses are delivering broad-based momentum, with 2Q26 organic growth of +7% across those segments, orders up ~10%, and backlog up ~20% Y/Y, which supports visibility into 2H26. Management’s raised 2026 adjusted EPS guidance to $8.80-$8.95, coupled with expected operating margin expansion of 70-80 bps and adjusted free cash flow conversion of +100%, suggests that productivity, pricing, and capital deployment are translating into higher-quality earnings. The recently spun-off healthcare business and the company’s diversified global footprint, with nearly half of revenue outside the Americas, further reinforce resilience, while large-scale innovation such as Microsoft-validated EBO technology adds a credible long-term growth driver.

3M is viewed negatively because its valuation still appears to embed significant downside while a large PFAS/Combat Arms liability burden remains unresolved, including about $11.5 billion unaddressed out of a $30 billion assumption. Although organic growth improved 5.4% Y/Y and adjusted operating margin rose 70 bps to 24.8%, those strengths are partly offset by 3, 2H26 tax timing reversal, continued softness in consumer and consumer electronics, and $574 million of after-tax litigation and PFAS exit cash payments in the quarter. The company also faces a long legal overhang with roughly 15,000 personal injury claims, five categories of unreserved PFAS exposure, and a structurally limited margin runway given already high profitability and 64% of sales outside the US.